The Clinical Features of Myositis-Associated Autoantibodies: a Review

被引:0
|
作者
Harsha Gunawardena
机构
[1] North Bristol NHS Trust,Clinical and Academic Rheumatology
[2] Southmead Hospital,undefined
关键词
Myopathy; Polymyositis; Dermatomyositis; Systemic sclerosis; Interstitial lung disease; Autoantibodies;
D O I
暂无
中图分类号
学科分类号
摘要
The idiopathic inflammatory myopathies (IIM) are a group of autoimmune diseases traditionally defined by clinical manifestations including skeletal muscle weakness, skin rashes, elevated skeletal muscle enzymes, and neurophysiological and/or histological evidence of muscle inflammation. Patients with myositis overlap can develop other features including parenchymal lung disease, inflammatory arthritis, gastrointestinal manifestations and marked constitutional symptoms. Although patients may be diagnosed as having polymyositis (PM) or dermatomyositis (DM) under the IIM spectrum, it is quite clear that disease course between subgroups of patients is different. For example, interstitial lung disease may predominate in some, whereas cutaneous complications, cancer risk, or severe refractory myopathy may be a significant feature in others. Therefore, tools that facilitate diagnosis and indicate which patients require more detailed investigation for disease complications are invaluable in clinical practice. The expanding field of autoantibodies (autoAbs) associated with connective tissue disease (CTD)-myositis overlap has generated considerable interest over the last few years. Using an immunological diagnostic approach, this group of heterogeneous conditions can be separated into a number of distinct clinical phenotypes. Rather than diagnose a patient as simply having PM, DM or overlap CTD, we can define syndromes to differentiate disease subsets that emphasise clinical outcomes and guide management. There are now over 15 CTD-myositis overlap autoAbs found in patients with a range of clinical manifestations including interstitial pneumonia, cutaneous disease, cancer-associated myositis and autoimmune-mediated necrotising myopathy. This review describes their diagnostic utility, potential role in disease monitoring and response to treatment. In the future, routine use of these autoAb will allow a stratified approach to managing this complex set of conditions.
引用
收藏
页码:45 / 57
页数:12
相关论文
共 50 条
  • [21] Distinguishing clinical features of JDM associated with a myositis-associated autoantibody (MAA) directed against a 155 kd protein.
    Mamyrova, G
    Targoff, I
    Lindsley, C
    Wallace, C
    Haftel, H
    Oral, E
    Cawkwell, G
    Finkel, T
    Gewanter, H
    Goldsmith, D
    Higgins, G
    Jones, O
    Katona, I
    Knee, M
    Lawton, A
    Morishima, C
    Passo, M
    Perez, M
    Person, D
    Rivas-Chacon, R
    Sherry, D
    Szer, I
    Zemel, L
    Miller, F
    Rider, L
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S514 - S514
  • [22] ANALYSIS OF THE PERFORMANCE OF COMMERCIAL TESTS IN THE DETERMINATION OF MYOSITIS-SPECIFIC AND MYOSITIS-ASSOCIATED AUTOANTIBODIES: PREVALENCE AND CORRELATION WITH DIAGNOSIS OF IIM
    Pedretti, E.
    Angeli, F.
    Fredi, M.
    Cavazzana, I.
    Andreoli, L.
    Garrafa, E.
    Franceschini, F.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1480 - 1481
  • [23] Myositis-associated interstitial lung disease
    Vu, Trang T. T.
    Brown, Kevin K. K.
    Solomon, Joshua J. J.
    [J]. CURRENT OPINION IN PULMONARY MEDICINE, 2023, 29 (05) : 427 - 435
  • [24] INNOVATIVE CLINICAL TRIAL OF NINTEDANIB IN MYOSITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE
    Aggarwal, Rohit
    Oddis, Chester
    Sullivan, Daniel I.
    Moghadam-Kia, Siamak
    Saygin, Didem
    Kass, Daniel
    Koontz, Diane
    Li, Peide
    Conoscenti, Craig S.
    Olson, Amy L.
    [J]. CHEST, 2023, 164 (04) : 3060A - 3062A
  • [25] EMERGING AUTOANTIBODIES PANEL (MYOSITIS ASSOCIATED AND MYOSITIS SPECIFIC ANTIBODIES) IN INFLAMMATORY MYOPATHIES: THE FREQUENCIES OF AND RELATIONSHIP WITH CLINICAL FEATURES
    Yardimci, G. K.
    Erul, E.
    Bilgin, E.
    Farisogullari, B.
    Kilic, L.
    Saribas, Z.
    Kalyoncu, U.
    Akdogan, A.
    Sener, B.
    Bilgen, S. A.
    Karadag, O.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1605 - 1606
  • [26] Insights into pathogenesis and clinical implications in myositis-associated interstitial lung diseases
    Yanagihara, Toyoshi
    Inoue, Yoshikazu
    [J]. CURRENT OPINION IN PULMONARY MEDICINE, 2020, 26 (05) : 507 - 517
  • [27] Anti-Cortactin Autoantibodies Are Associated With Key Clinical Features in Adult Myositis but Are Rarely Present in Juvenile Myositis
    Pinal-Fernandez, Iago
    Pak, Katherine
    Gil-Vila, Albert
    Baucells, Andres
    Plotz, Benjamin
    Casal-Dominguez, Maria
    Derfoul, Assia
    Martinez-Carretero, Maria Angeles
    Selva-O'Callaghan, Albert
    Sabbagh, Sara
    Casciola-Rosen, Livia
    Albayda, Jemima
    Paik, Julie
    Tiniakou, Eleni
    Danoff, Sonye K.
    Lloyd, Thomas E.
    Miller, Frederick W.
    Rider, Lisa G.
    Christopher-Stine, Lisa
    Mammen, Andrew L.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 (02) : 358 - 364
  • [28] Anti-cortactin Autoantibodies Are Associated with Key Clinical Features in Adult Myositis but Are Rarely Present in Juvenile Myositis
    Pinal-Fernandez, Iago
    Pak, Katherine
    Gil-Vila, Albert
    Baucells, Andres
    Plotz, Benjamin
    Casal-Dominguez, Maria
    Derfoul, Assia
    Angeles Martinez, Maria
    Selva-O'Callaghan, Albert
    Sabbagh, Sara
    Miller, Frederick W.
    Rider, Lisa G.
    Christopher-Stine, Lisa
    Mammen, Andrew
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [29] Myositis-associated, myositis-specific and organ-specific autoantibodies in inflammatory myopathies: A West Australian population control study
    Rojana-udomsart, A.
    Bundell, C.
    Hollingsworth, P.
    Mastaglia, F. L.
    [J]. NEUROMUSCULAR DISORDERS, 2012, 22 (9-10) : 853 - 853
  • [30] The use and diagnostic value of testing myositis-specific and myositis-associated autoantibodies by line immuno-assay: a retrospective study
    Lackner, Angelika
    Tiefenthaler, Viktoria
    Mirzayeva, Jalia
    Posch, Florian
    Rossmann, Christopher
    Kastrati, Kastriot
    Radner, Helga
    Demel, Ulrike
    Gretler, Judith
    Stotz, Michael
    Graninger, Winfried B.
    Stradner, Martin H.
    [J]. THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2020, 12